Drug Description in Trials / DrugBank / KEGG DRUG /

Search results

descriptions per page:

Showing 1 to 10 of 28 descriptions

Filter by

No.	薬物名（臨床試験情報から抽出）	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY	指定難病告示番号
1	68Ga-NEB	-	-	-	-	3件: 46, 89, 280
2	Bevacizumab	1件: Bevacizumab	1件: D06409	1件: VEGFA 💬	24件: AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway ...	6件: 13, 34, 85, 87, 227, 280
3	Bleomycin	1件: Bleomycin	1件: D07535	-	-	4件: 96, 278, 279, 280
4	Blood sample	-	-	-	-	20件: 8, 13, 46, 49, 51, 53, 61, 66, 84, 88, 96, 97, 107, 127, 235, 274, 280, 288, 294, 299
5	Blood samples	-	-	-	-	9件: 13, 41, 51, 61, 97, 227, 240, 271, 280
6	Cobimetinib	1件: Cobimetinib	1件: D10405	2件: MAP2K1, MAP2K2 💬	89件: Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Aut ...	1件: 280
7	DEXMEDETOMIDINE	1件: Dexmedetomidine	1件: D00514	3件: ADRA2A, ADRA2B, ADRA2C 💬	2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬	14件: 2, 4, 6, 21, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280
8	Dexmedetomidine 1	1件: Dexmedetomidine	1件: D00514	3件: ADRA2A, ADRA2B, ADRA2C 💬	2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬	1件: 280
9	Dexmedetomidine 2	1件: Dexmedetomidine	1件: D00514	3件: ADRA2A, ADRA2B, ADRA2C 💬	2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬	1件: 280
10	Dexmedetomidine 3	1件: Dexmedetomidine	1件: D00514	3件: ADRA2A, ADRA2B, ADRA2C 💬	2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬	1件: 280

First Previous1 2 3Next Last